Cargando…
miR‐132 loss de‐represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer's brain
microRNA‐132 (miR‐132) is involved in prosurvival, anti‐inflammatory and memory‐promoting functions in the nervous system and has been found consistently downregulated in Alzheimer's disease (AD). Whether and how miR‐132 deficiency impacts AD pathology remains, however, unaddressed. We show her...
Autores principales: | Salta, Evgenia, Sierksma, Annerieke, Vanden Eynden, Elke, De Strooper, Bart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009807/ https://www.ncbi.nlm.nih.gov/pubmed/27485122 http://dx.doi.org/10.15252/emmm.201606520 |
Ejemplares similares
-
Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology
por: Sierksma, Annerieke, et al.
Publicado: (2018) -
Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
por: Sierksma, Annerieke, et al.
Publicado: (2020) -
microRNA-132 regulates gene expression programs involved in microglial homeostasis
por: Walgrave, Hannah, et al.
Publicado: (2023) -
From Junk to Function: LncRNAs in CNS Health and Disease
por: Policarpo, Rafaela, et al.
Publicado: (2021) -
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
por: Walgrave, Hannah, et al.
Publicado: (2021)